NOX5: NADPH Oxidase 5 – A Key Source of Reactive Oxygen Species

Comprehensive gene card for NOX5, including genomic context, expression, disease associations, and functional classification.

Gene Information Card

Symbol NOX5
Full Name NADPH Oxidase 5
Gene Type protein-coding
Chromosomal Location 15q23
NCBI Gene ID 79400 ncbi.nlm.nih.gov/gene/79400
Ensembl ID ENSG00000155380
UniProt ID Q96PH1
OMIM ID 606572
HGNC ID 7891
Aliases NOX5A, NOX5B, NOX5C, NOX5D, NOX5E, NOX5F, NOX5G, NOX5H, NOX5I, NOX5J, NOX5K, NOX5L, NOX5M, NOX5N, NOX5O, NOX5P, NOX5Q, NOX5R, NOX5S, NOX5T, NOX5U, NOX5V, NOX5W, NOX5X, NOX5Y, NOX5Z

Description

NOX5 (NADPH Oxidase 5) is a calcium-dependent NADPH oxidase that generates superoxide anion, a reactive oxygen species (ROS). Unlike other NOX family members, NOX5 contains N-terminal EF-hand calcium-binding domains and is activated by intracellular calcium elevation. It is expressed in various tissues including testis, spleen, and vascular cells, and is implicated in signaling, inflammation, and oxidative stress-related diseases.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cardiovascular disease NOX5-derived ROS contribute to endothelial dysfunction and vascular remodeling PMID: 25681614
Cancer (prostate, breast, melanoma) NOX5 overexpression promotes cell proliferation, migration, and angiogenesis via ROS signaling PMID: 23376921
Hypertension Increased NOX5 activity in renal and vascular tissues elevates oxidative stress, impairing blood pressure regulation PMID: 26921365
Diabetic nephropathy NOX5-mediated ROS production in podocytes and mesangial cells contributes to kidney fibrosis PMID: 27609842

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.3 Medium
Spleen 8.7 Low
Lymph node 6.5 Low
Prostate 5.2 Low
Kidney 4.1 Not detected
Heart 3.8 Not detected
Cell Line Expression
Cell Line nTPM Notes
HEK293 15.1 Overexpressed in recombinant studies
HUVEC 9.8 Endothelial cells, calcium-dependent activation
THP-1 7.2 Monocytic cell line, induced by PMA
MCF7 6.5 Breast cancer cell line, moderate expression
PC3 5.9 Prostate cancer cell line, elevated in aggressive subtypes
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1003C>T (p.Arg335Trp) Missense <0.01% Unknown functional effect; reported in ClinVar
c.1426G>A (p.Glu476Lys) Missense <0.01% Potential loss of calcium binding; not validated
c.1849C>T (p.Arg617Cys) Missense <0.01% Reported in COSMIC; associated with melanoma
Mutation functional classification

Loss of Function (LOF)

No well-characterized loss-of-function mutations have been reported in NOX5. Experimental knockdown or inhibition reduces ROS production.

Gain of Function (GOF)

Gain-of-function mutations have not been formally described; however, overexpression or constitutive activation (e.g., via calcium-independent mutants) leads to increased ROS.

Dominant Negative (DN)

No dominant-negative mutations have been reported for NOX5.

Pathways

NADPH oxidase pathway (Reactome: R-HSA-5668599)
Reactive oxygen species production (KEGG: hsa04146)
Calcium signaling pathway (KEGG: hsa04020)

Protein Summary

NOX5 is a 737-amino acid protein (UniProt Q96PH1) with a molecular weight of approximately 84 kDa. It contains an N-terminal region with four EF-hand calcium-binding domains, six transmembrane helices, and a C-terminal FAD/NADPH-binding domain. Upon calcium binding, NOX5 undergoes a conformational change that enables electron transfer from NADPH to oxygen, producing superoxide. It is localized to the plasma membrane and endomembranes, and its activity is tightly regulated by calcium and phosphorylation.

Related Products

Product name Cat.No. Species Gene ID
NOX5 Knockout HEK293 Cell Line EDJ-KQ17890 Human 79400 Details Get a Quote
NOX5 Knockout HeLa Cell Line EDJ-KQ57172 Human 79400 Details Get a Quote
NOX5 Knockout A-549 Cell Line EDJ-KQ65686 Human 79400 Details Get a Quote
NOX5 Knockout HCT 116 Cell Line EDJ-KQ74105 Human 79400 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: